CHABS 2026 Annual Conference

Biointron is pleased to announce that we will be attending the CHABS 2026 Annual Conference, hosted by the Chinese Antibody Society (CHABS). The event brings together scientists, industry leaders, and innovators from across the global biopharmaceutical community to discuss the latest advances in antibody therapeutics and related modalities.

The CHABS Annual Conference is recognized as a focused forum for cutting-edge developments in antibody discovery, engineering, and clinical translation. The program typically features scientific presentations, panel discussions, and networking opportunities covering topics such as novel antibody formats, bispecifics, ADCs, and emerging technologies shaping the future of biologics. It serves as a valuable platform for fostering collaboration between academia, biotech, and pharmaceutical organizations.

As a company specializing in antibody discovery and engineering, Biointron looks forward to engaging with peers, exchanging technical insights, and exploring potential collaborations that accelerate therapeutic innovation. Participation in CHABS aligns with our commitment to advancing high-quality antibody candidates from early discovery through development.

We look forward to connecting with colleagues at the CHABS 2026 Annual Conference and contributing to discussions that drive progress in antibody-based therapeutics!

For more details about the event, please visit the CHABS 2026 Annual Conference website [https://www.chabs.org/events-1/2026-annual-conference] 

Time: May 9 - 10, 2026 

Location: Boston Marriott Cambridge | Boston, MA